Indeed, and in agreement with previously reported results by Katano et al. using synovial fluid from RA and OA patients [24], we also observed higher serum levels of LCN2 in RA patients treated with conventional therapy, with a worse inflammatory profile, in comparison to the OA group. This evidence concerns the gene LCN2 and rheumatoid arthritis.